111In-ABD-320

N/A

Report date: 2025/10/21 15:09:18

Base Information

Drug Name111In-ABD-320

Drug Alias NameN/A

ClassificationRadiation-emitting products > Nuclides > Indium > 111InRadiation-emitting products > Radioactive therapeutic agentRadiation-emitting products > Radionuclide Drug Conjugates

Mechanisms of ActionTrophoblast glycoprotein modulators

TargetsTrophoblast glycoprotein

Therapy Area/IndicationsNeoplasms

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryUnited States

CombinationsNo

Global Highest StatusPreclinical

Highest Status in ChinaN/A

Originator CompaniesAbdera Therapeutics Inc

China Registration ClassN/A

Develop Information

Active CompaniesAbdera Therapeutics Inc

Inactive CompaniesN/A

Active IndicationsNeoplasms

Inactive IndicationsN/A

Other Information

ATC CodeN/A